tm
Seeing Is Believing
tm
Seeing Is Believing
BHVN is currently covered by 4 analysts with an average potential upside of $15.5 (35.29%) from yesterday's end of day stock price of $33.32. Biohaven Pharmaceutical Holding Company Ltd activity chart has currently 0 price targets and 13 ratings on display.
Analysts average stock forecasts to be materialized ratio is 94.62% with an average time for these price targets to be met of 192.69 days.
Highest price target for BHVN is $31, Lowest price target is $13, average price target is $22.
Most recent stock forecast was given by TESSA ROMERO from JPMORGAN on 20-Nov-2023. First documented stock forecast 26-Oct-2022.
Currently, out of the existing stock ratings of BHVN - 13 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
32
$-1.32 (-3.96%)
24
14 days ago
6/6 (100%)
$5.12 (32.39%)
63
Buy
36
$2.68 (8.04%)
21
19 days ago
2/3 (66.67%)
$6.53 (37.21%)
181
Buy
31
$-2.32 (-6.96%)
27
4 months 17 days ago
2/2 (100%)
$8.96 (57.45%)
162
Hold
100
1 years 3 months 26 days ago
8/8 (100%)
$22.61 (37.88%)
172
Hold
146
1 years 6 months 23 days ago
20/20 (100%)
$2.02 (6.04%)
208
What is BHVN (Biohaven Pharmaceutical Holding Company Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on BHVN (Biohaven Pharmaceutical Holding Company Ltd) with a proven track record?
Which analyst has the most public recommendations on BHVN (Biohaven Pharmaceutical Holding Company Ltd)?
Which analyst is the currently most bullish on BHVN (Biohaven Pharmaceutical Holding Company Ltd)?
Which analyst is the currently most reserved on BHVN (Biohaven Pharmaceutical Holding Company Ltd)?
